Compare Stock Earnings
Side-by-side earnings, revenue, and financial performance comparison
Ultragenyx Pharmaceutical Inc
$24.35
+1.54%
Mkt Cap: $2.4B
Avg ER Move: ±3.9%
Next Earnings
Aug 4, 2026
In 50 days
Consensus EPS
$-1.14
Whisper EPS
$-1.14
Earnings Track Record (7Q)
2 Beats
5 Misses
Whisper Beat: 29%
Last 4 Quarters
Q2'26
$-1.54
❌ MISS -5.5%
📈 +3.7%
Q2'26
$-1.54
❌ MISS -15%
📈 +0.3%
Q1'26
$-1.29
❌ MISS -10.3%
📉 -12.7%
$207.0M
Q4'25
$-1.81
❌ MISS -49.6%
📉 -1.0%
$159.9M
Latest Revenue
$207.0M
+25.6% YoY
Gross: 86.0%
Op: -55.1%
Net: -62.3%